Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08VUO
|
|||
| Former ID |
DNC014295
|
|||
| Drug Name |
Ethyl 2beta-hydroxyolean-12-en-28-oate
|
|||
| Synonyms |
CHEMBL1077973; Ethyl 2beta-hydroxyolean-12-en-28-oate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H52O3
|
|||
| Canonical SMILES |
CCOC(=O)C12CCC(CC1C3=CCC4C(C3(CC2)C)(CCC5C4(CC(CC5(C)C)O)C)C)(C)C
|
|||
| InChI |
1S/C32H52O3/c1-9-35-26(34)32-16-14-27(2,3)20-23(32)22-10-11-25-29(6)19-21(33)18-28(4,5)24(29)12-13-31(25,8)30(22,7)15-17-32/h10,21,23-25,33H,9,11-20H2,1-8H3/t21-,23+,24+,25-,29+,30-,31-,32+/m1/s1
|
|||
| InChIKey |
ZGVDWCUGEWKVJU-UMIBNUPHSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [1] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase. J Nat Prod. 2009 Aug;72(8):1414-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.